Greef, Basma
Eisen, Tim
Article History
Received: 21 March 2016
Revised: 6 June 2016
Accepted: 29 June 2016
First Online: 4 August 2016
Competing interests
: TE is currently on 80% leave of absence from the University of Cambridge currently working as VP Oncology Translational Medicine Unit and VP Clinical Discovery Unit, Astrazeneca, Cambridge UK, advisory boards for AVEO, BMS, Bayer, GSK, Pfizer. Research support from AstraZeneca, Bayer and Pfizer. The remaining authors declare no conflict of interest.